Product Images Tilia Fe

This appears to be a table showing the steady-state pharmacokinetic parameters following chronic administration of norethindrone acetate and ethinyl estradiol tablets. It includes information on the maximum plasma concentration, area under the plasma concentration-time curve over the dosing interval, and apparent oral clearance for different dosages of norethindrone acetate and ethinyl estradiol. There is also a baseline value provided.*

This is a graph (Figure 2) that shows the mean percent reduction in total lesion counts over 6 cycles of treatment with norethindrone acetate and ethinyl estradiol tablets compared to placebo. The graph shows that there was a statistically significant difference between the two treatments at cycle 6. The intent-to-treat population was used, and the mean total lesion counts for each cycle were provided for both the treatment group (NDAG/EE) and the placebo group.*

This is a figure showing circulatory disease mortality rates per 100,000 woman years by age, smoking status, and oral contraceptive use. The chart displays the number of deaths per 100,000 woman users (both over-users and controls) for different age ranges (15-24, 25-34, 35-44, 45+). The chart is adapted from PM Layde and V. Beral, but no further information is given.*

This table presents the annual number of birth-related or method-related deaths associated with the control of fertility per 100,000 nonsterile women by fertility control method according to age. The presented data show the method of control and the outcome for age-groups of 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44 years old. The methods of fertility control analyzed include no method, oral contraceptives for smokers and non-smokers, D, condoms, diaphragm/spermicide, and periodic abstinence. Note that deaths are either birth-related or method-related.*

This text seems to be instructional information on what to do when starting a new pack of birth control pills. It gives guidelines for how to label the pack based on when the period starts and shows an example pack with different colored tablets for different days. The text also provides instructions on how to take the pills, from left to right.*

This text presents data on the annual number of birth-related or method-related deaths associated with various fertility control methods per 100,000 non-sterile women, arranged by age group. The methods included are no fertility control methods, oral contraceptives for nonsmokers, oral contraceptives for smokers, D, condom, diaphragm with spermicide, and periodic abstinence. The data shows the number of deaths per year resulting from each method and the age group of the women using them.*

This appears to be instructions for a birth control pill pack. It includes information on how to start the pack depending on the day a person's period begins and which sticker to place on the packaging. The pack contains pale yellow and light yellow active tablets as well as light brown active tablets. There are also instructions on the direction to take the pills.*

This is an advertisement for Tilia Fe tablets, which are a combination of Norethindrone Acetate, Ethinyl Estradiol and Ferrous Fumarate. The tablets are available in different dosages and each package contains three blister cards, with two tablets each. The tablets are used to prevent pregnancy and protect against sexually transmitted infections. The text also includes some dosage information and contact details for the manufacturer.*